Baclofen reduces ethanol intake in high-alcohol-drinking University of Chile bibulous rats - PubMed (original) (raw)
Baclofen reduces ethanol intake in high-alcohol-drinking University of Chile bibulous rats
María E Quintanilla et al. Addict Biol. 2008 Sep.
Abstract
ABSTRACT Treatment with gamma-aminobutiric acid (GABA(B)) receptor agonist, +/-baclofen, has been shown to reduce ethanol intake in selectively bred Sardinian alcohol-preferring rats. The general goal of the present study was to characterize the high ethanol consumption high-alcohol-drinking University of Chile bibulous (UChB) rats with regard to the anti-alcohol effect of GABA(B) receptor stimulation. UChB rats were treated with the more active enantiomer of baclofen [R(+)-baclofen; at a dose of 1.0, 2.0 or 3.0 mg/kg] administered intraperitoneally once daily for four consecutive days or a single dose. When comparing ethanol and saccharin consumption in a free-choice regimen with unlimited access 24 hours/day, the dose of baclofen required to attenuate ethanol consumption significantly was 1.0 mg/kg administered once a day for three consecutive days while the dose that was sufficient to affect saccharin consumption significantly was 2.0 mg/kg, indicating that baclofen was more potent in reducing ethanol intake by UChB rats than reducing saccharin consumption. The reduction of ethanol or saccharin intake can not be attributed to baclofen-induced motor impairment, since baclofen (1.0, 2.0 or 3.0 mg/kg) did not alter spontaneous locomotor activity in UChB rats. Baclofen dose-dependently suppressed the motor activity stimulated by ethanol administration, a phenomenon mediated by activation of the mesolimbic dopamine system. In conclusion, these results showed that the activation of GABA(B) receptor by R(+)-baclofen reduced ethanol and saccharin consumption, as well as ethanol-induced motor stimulation, implicating the GABA(B) receptor in the neural substrates mediating effects that sustain voluntary ethanol in take in UChB rats.
Similar articles
- Effect of concurrent saccharin intake on ethanol consumption by high-alcohol-drinking (UChB) rats.
Tampier L, Quintanilla ME. Tampier L, et al. Addict Biol. 2009 Jul;14(3):276-82. doi: 10.1111/j.1369-1600.2009.00147.x. Epub 2009 Apr 28. Addict Biol. 2009. PMID: 19413565 - Ability of baclofen in reducing alcohol intake and withdrawal severity: I--Preclinical evidence.
Colombo G, Agabio R, Carai MA, Lobina C, Pani M, Reali R, Addolorato G, Gessa GL. Colombo G, et al. Alcohol Clin Exp Res. 2000 Jan;24(1):58-66. Alcohol Clin Exp Res. 2000. PMID: 10656194 - Baclofen-induced reduction of alcohol reinforcement in alcohol-preferring rats.
Maccioni P, Serra S, Vacca G, Orrù A, Pes D, Agabio R, Addolorato G, Carai MA, Gessa GL, Colombo G. Maccioni P, et al. Alcohol. 2005 Jul;36(3):161-8. doi: 10.1016/j.alcohol.2005.08.003. Alcohol. 2005. PMID: 16377457 - Phenotypic characterization of genetically selected Sardinian alcohol-preferring (sP) and -non-preferring (sNP) rats.
Colombo G, Lobina C, Carai MA, Gessa GL. Colombo G, et al. Addict Biol. 2006 Sep;11(3-4):324-38. doi: 10.1111/j.1369-1600.2006.00031.x. Addict Biol. 2006. PMID: 16961762 Review.
Cited by
- Activation of the GABA(B) Receptor Prevents Nicotine-Induced Locomotor Stimulation in Mice.
Lobina C, Carai MA, Froestl W, Mugnaini C, Pasquini S, Corelli F, Gessa GL, Colombo G. Lobina C, et al. Front Psychiatry. 2011 Dec 30;2:76. doi: 10.3389/fpsyt.2011.00076. eCollection 2011. Front Psychiatry. 2011. PMID: 22232609 Free PMC article. - Comparison of the effect of the GABAΒ receptor agonist, baclofen, and the positive allosteric modulator of the GABAB receptor, GS39783, on alcohol self-administration in 3 different lines of alcohol-preferring rats.
Maccioni P, Zaru A, Loi B, Lobina C, Carai MA, Gessa GL, Capra A, Mugnaini C, Pasquini S, Corelli F, Hyytiä P, Lumeng L, Colombo G. Maccioni P, et al. Alcohol Clin Exp Res. 2012 Oct;36(10):1748-66. doi: 10.1111/j.1530-0277.2012.01782.x. Epub 2012 Apr 6. Alcohol Clin Exp Res. 2012. PMID: 22486245 Free PMC article. - GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence.
Agabio R, Colombo G. Agabio R, et al. Front Neurosci. 2014 Jun 6;8:140. doi: 10.3389/fnins.2014.00140. eCollection 2014. Front Neurosci. 2014. PMID: 24936171 Free PMC article. Review. - Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.
Bell RL, Sable HJ, Colombo G, Hyytia P, Rodd ZA, Lumeng L. Bell RL, et al. Pharmacol Biochem Behav. 2012 Nov;103(1):119-55. doi: 10.1016/j.pbb.2012.07.007. Epub 2012 Jul 25. Pharmacol Biochem Behav. 2012. PMID: 22841890 Free PMC article. Review. - Reducing effect of the novel positive allosteric modulator of the GABAB receptor, COR659, on binge-like alcohol drinking in male mice and rats.
Lorrai I, Shankula C, Gaytan JM, Kawamura T, Maccioni P, Mugnaini C, Corelli F, Gessa GL, Sanna PP, Colombo G. Lorrai I, et al. Psychopharmacology (Berl). 2022 Jan;239(1):201-213. doi: 10.1007/s00213-021-06022-3. Epub 2021 Nov 23. Psychopharmacology (Berl). 2022. PMID: 34812900
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical